{'Year': '2016'}
Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients.
Methotrexate (MTX) is the most used drug for the treatment of rheumatoid arthritis (RA) although outcome differs among patients.